ResMed (RMD) stock valuation

$240.75 Nov 18, 2026 · market cap $35.2B

9/121 investors
i

ResMed trades at $241. Our three models put it at $156–$309 (base $260): 8% below the base.

Cash Flow $309 · Buffett $260 · Damodaran $156 · models run Nov 18, 2026

9 of 121 tracked investors hold it · Q3 2026 13F filings

Estimates from SEC filings and market data; the verdict is AI research. Not investment advice. Get the iPhone app · Get the Android app

5 AI analysts debate RMDCreate free account →

Full open-source research report for RMD on DeepValues Research (CC BY 4.0)